pomalidomide: Clinical Trials

3 trials of pomalidomide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 withdrawn. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Not yet recruiting 1, Withdrawn 1

Follow pomalidomide: new trials by email Literature Review of pomalidomide trials Research Report on pomalidomide

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pomalidomide Plus Rituximab Maintenance in Young High-Risk Newly Diagnosed DLBCL After First-Line Response
Pomalidomide, Rituximab - Diffuse Large B-Cell Lymphoma (DLBCL)
Phase 4Not yet recruitingThe First Hospital of Jilin University272026-09-012026-08-12
Alternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative Study
Pomalidomide 4 mg every day in cycle 1, Pomalidomide 4 mg every other day in cycle 2, Pomalidomide 2 mg every day in cycle 2 - Multiple Myeloma in Relapse, Multiple Myeloma
Phase 4CompletedAmsterdam UMC, location VUmc122022-12-012025-04-22
A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma
Ixazomib, Pomalidomide, Lenalidomide - Multiple Myeloma
Phase 4WithdrawnTakeda2022-06-302022-05-03

Conditions studied

Multiple Myeloma (2)  ·  Lymphoma, Large B-Cell, Diffuse (1)

Sponsors

Amsterdam UMC, location VUmc (1)  ·  Takeda (1)  ·  The First Hospital of Jilin University (1)

Countries

Netherlands (1)

Top investigators

Sonja Zweegman, MD PhD (1)